Dopaminergic and cholinergic interaction in cataleptic responses in mice

被引:19
作者
Ushijima, I
Kawano, M
Kaneyuki, H
Suetsugi, M
Usami, K
Hirano, H
Mizuki, Y
Yamada, M
机构
[1] Department of Neuropsychiatry, Yamaguchi Univ. Sch. Med., 1144 K., Ube
关键词
catalepsy; haloperidol; SCH23390; physostigmine; pilocarpine; mice;
D O I
10.1016/S0091-3057(96)00478-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The cataleptogenic effects of haloperidol, a dopamine D2 receptor antagonist; SCH23390, a D1 receptor antagonist; physostigmine, a cholinesterase inhibitor; and pilocarpine, a muscarinic M1 receptor agonist, were challenged by pretreatment of mice with SKF38393, a dopamine D1 receptor agonist; apomorphine, a dopamine D1/D2 receptor agonist (mainly D2 receptor); pirenzepine, a muscarinic M1 receptor antagonist; and scopolamine, a muscarinic M1/M2 receptor antagonist. The effect of physostigmine and pilocarpine on haloperidol and SCH23390 cataleptic responses was also examined. Each of the challenging agents blocked one or more of the cataleptogenic agents, but only scopolamine blocked all four. Pirenzepine blocked cataleptic responses induced by SCH23390 and pilocarpine, but not those by haloperidol and physostigmine. The results of this study suggest that the action of physostigmine (endogenous acetylcholine) on M2 receptors might be more potent than that on muscarinic M1 receptors. A further interesting observation was that the haloperidol-induced catalepsy was enhanced by physostigmine pretreatment, but not by pilocarpine pretreatment, whereas the SCH23390-induced catalepsy showed the opposite spectrum of enhancement by the two cholinergic agonists. We conclude that, although the four cataleptogenic agents act via the dopaminergic-cholinergic systems, their pharmacological differences may be due largely to the different receptor subtypes that are involved in the mediation of catalepsy produced by each agent. Thus, dopamine receptors not only influence the cholinergic muscarinic receptors, but muscarinic M1 and M2 receptors also might mediate dopamine DI and D2 receptor responses, respectively. The results suggest that there are, at the least, relationships between muscarinic M1 receptors and dopaminergic DI receptors, and between muscarinic M2 receptors and dopaminergic D2 receptors. Dopamine D1 and D2 receptors may interact in a synergistic fashion on dopaminergic systems, but act independently,of each other in influencing other system such as cholinergic neurons. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 26 条
[1]   SMALL DOSES OF APOMORPHINE INDUCE CATALEPSY AND ANTAGONIZE METHAMPHETAMINE STEREOTYPY IN RATS [J].
BALSARA, JJ ;
BAPAT, TR ;
GADA, VP ;
CHANDORKAR, AG .
PSYCHOPHARMACOLOGY, 1982, 78 (02) :192-194
[2]   [H-3] 205-501, A NON-CATECHOL DOPAMINERGIC AGONIST, LABELS SELECTIVELY AND WITH HIGH-AFFINITY DOPAMINE D2-RECEPTORS [J].
CLOSSE, A ;
FRICK, W ;
MARKSTEIN, R ;
MAURER, R ;
NORDMANN, R .
JOURNAL OF NEURAL TRANSMISSION, 1985, 62 (3-4) :231-248
[3]   CATALEPSY AND CIRCLING BEHAVIOR AFTER INTRACEREBRAL INJECTIONS OF NEUROLEPTIC, CHOLINERGIC AND ANTICHOLINERGIC AGENTS INTO CAUDATE-PUTAMEN, GLOBUS PALLIDUS AND SUBSTANTIA NIGRA OF RAT-BRAIN [J].
COSTALL, B ;
NAYLOR, RJ ;
OLLEY, JE .
NEUROPHARMACOLOGY, 1972, 11 (05) :645-+
[4]   MUSCULAR RIGIDITY AND DELINEATION OF A DOPAMINE-SPECIFIC NEOSTRIATAL SUBREGION - TONIC EMG ACTIVITY IN RATS [J].
ELLENBROEK, B ;
SCHWARZ, M ;
SONTAG, KH ;
JASPERS, R ;
COOLS, A .
BRAIN RESEARCH, 1985, 345 (01) :132-140
[5]   BEHAVIORAL CORRELATIONS OF DOPAMINE RECEPTOR ACTIVATION [J].
GERSHANIK, O ;
HEIKKILA, RE ;
DUVOISIN, RC .
NEUROLOGY, 1983, 33 (11) :1489-1492
[6]   MODIFICATION OF APOMORPHINE INDUCED AGGRESSION BY CHANGING CENTRAL CHOLINERGIC ACTIVITY IN RATS [J].
GIANUTSOS, G ;
LAL, H .
NEUROPHARMACOLOGY, 1977, 16 (01) :7-10
[7]   ROLE OF MESENCEPHALIC RETICULAR-FORMATION IN CHOLINERGIC-INDUCED CATALEPSY AND ANTICHOLINERGIC REVERSAL OF NEUROLEPTIC-INDUCED CATALEPSY [J].
HARTGRAVES, SL ;
KELLY, PH .
BRAIN RESEARCH, 1984, 307 (1-2) :47-54
[8]  
JACKSON DM, 1986, PSYCHOPHARMACOLOGY, V90, P147
[9]   EVIDENCE FOR A CHOLINERGIC ROLE IN HALOPERIDOL-INDUCED CATALEPSY [J].
KLEMM, WR .
PSYCHOPHARMACOLOGY, 1985, 85 (02) :139-142